Gene · 6295
Papers1,541
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,541
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A visual opsin from jellyfish enables precise temporal control of G protein signalling. | Nat Commun | 2023 | 37117224 | PubTator, text mining | PubMed |
| A 5-year-old Syrian female was born with Oguchi disease: a rare case report. | Ann Med Surg (Lond) | 2023 | 37113844 | PubTator, text mining | PubMed |
| Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial. | Oncologist | 2023 | 37104870 | PubTator, text mining | PubMed |
| Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. | Hepatol Commun | 2023 | 37102765 | PubTator, text mining | PubMed |
| Unique Haplotypes in OPN1LW as a Common Cause of High Myopia With or Without Protanopia: A Potential Window Into Myopic Mechanism. | Invest Ophthalmol Vis Sci | 2023 | 37097228 | PubTator, text mining | PubMed |
| The therapeutic potential of neurofibromin signaling pathways and binding partners. | Commun Biol | 2023 | 37081086 | PubTator, text mining | PubMed |
| Descending necrotizing mediastinitis caused by Streptococcus constellatus: A case report and review of the literature. | Medicine (Baltimore) | 2023 | 37026905 | PubTator, text mining | PubMed |
| Factors and Mechanisms Influencing Conjugation In Vivo in the Gastrointestinal Tract Environment: A Review. | Int J Mol Sci | 2023 | 36982992 | PubTator, text mining | PubMed |
| Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review. | Children (Basel) | 2023 | 36979992 | PubTator, text mining | PubMed |
| New insights into GPCR coupling and dimerisation from cryo-EM structures. | Curr Opin Struct Biol | 2023 | 36963163 | PubTator, text mining | PubMed |
| E3-ubiquitin ligases and recent progress in osteoimmunology. | Front Immunol | 2023 | 36911671 | PubTator, text mining | PubMed |
| Distributed Thermal Monitoring of High-Voltage Power Lines. | Sensors (Basel) | 2023 | 36904603 | PubTator, text mining | PubMed |
| Role of Monomer/Tetramer Equilibrium of Rod Visual Arrestin in the Interaction with Phosphorylated Rhodopsin. | Int J Mol Sci | 2023 | 36902393 | PubTator, text mining | PubMed |
| Rapid Dissemination followed by Spontaneous Regression of Metastatic Hepatocellular Carcinoma after Liver Radiofrequency Thermal Ablation: A Case Report with Correlative Immune Assay. | Case Rep Oncol | 2023 | 36876217 | PubTator, text mining | PubMed |
| Mouse mammary tumor virus is implicated in severity of colitis and dysbiosis in the IL-10-/- mouse model of inflammatory bowel disease. | Microbiome | 2023 | 36869359 | PubTator, text mining | PubMed |
| The salivary protein Saglin facilitates efficient midgut colonization of Anopheles mosquitoes by malaria parasites. | PLoS Pathog | 2023 | 36862755 | PubTator, text mining | PubMed |
| Research into the characteristic molecules significantly affecting liver cancer immunotherapy. | Front Immunol | 2023 | 36860864 | PubTator, text mining | PubMed |
| Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID. | Viruses | 2023 | 36851614 | PubTator, text mining | PubMed |
| Sub-cellular level resolution of common genetic variation in the photoreceptor layer identifies continuum between rare disease and common variation. | PLoS Genet | 2023 | 36848389 | PubTator, text mining | PubMed |
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study. | Front Oncol | 2023 | 36845751 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6295/papers?page=8